Arcadia Biosciences, Inc.
RKDA
$3.15
$0.155.00%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -271.53% | 163.95% | -152.11% | -251.93% | 143.79% |
| Total Depreciation and Amortization | -76.07% | -31.58% | 8.92% | -24.88% | -8.33% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 184.82% | -267.19% | 3,815.52% | 98.38% | -760.43% |
| Change in Net Operating Assets | 5.99% | -48.83% | -97.07% | -73.19% | 76.92% |
| Cash from Operations | -28.02% | 28.11% | -26.08% | 28.66% | 23.49% |
| Capital Expenditure | -- | -- | -- | 100.00% | 76.92% |
| Sale of Property, Plant, and Equipment | -- | -- | -104.44% | 24.14% | 752.94% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -50.00% | -80.18% | -- | -100.00% | -- |
| Cash from Investing | -50.00% | -80.12% | 1,297.22% | -96.12% | 115,975.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -100.00% | -- | -100.00% | -- | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -100.00% | -- | -100.00% | -- | -100.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -64.64% | -453.92% | 119.52% | -171.70% | 168.32% |